Tuesday, April 17, 2012

Device maker Intersect ENT grows with move to Menlo Park

Intersect ENT Inc. will move from Palo Alto to new headquarters in Menlo Park, quadrupling its space as it commercializes its device to treat chronic sinusitis.
The 32,000-square-foot facility at 1555 Adams Drive will house all business and manufacturing operations for Propel, a stent that is placed in the sinus cavities right after sinus surgery. The device keeps the sinuses open and releases corticosteroid over a period of time before dissolving.

No comments:

Post a Comment